SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Director/PDMR Shareholding

30 Jun 2025 12:30

RNS Number : 0073P
Accsys Technologies PLC
30 June 2025
 

Accsys Technologies PLC (the "Company")

Director/PDMR Grant of Share Awards under the Accsys Deferred Bonus Plan and under the Accsys Long Term Incentive Plan and Issue of Shares

The Company announces that following recommendation from its Remuneration Committee, on 27 June 2025 (the "Grant Date") it granted awards over 2,248,645 ordinary shares of €0.05 each in the Company ("Shares") under its Deferred Bonus Plan ("DBP") and granted nil cost options over 1,883,769 Shares under its 2025 Long Term Incentive Plan ("LTIP") to certain employees and the Company's Executive Directors, Jelena Arsic van Os and Sameet Vohra, as further set out below.

Deferred Bonus Plan

Awards under the DBP have been granted in respect of bonuses earned for the financial year ending 31 March 2025 over a total of 2,248,645 Shares (the "Bonus Shares"), including to the Executive Directors in such numbers as set out below. The awards to Executive Directors vest 80% on the Grant Date and 20% on the second anniversary of the Grant Date, subject in each case to the sale of such number of Bonus Shares as is required to cover each Director's respective tax and social security liabilities.

Director

Role

Number of Bonus Shares awarded

Number of Bonus Shares vesting on Grant Date

Number of Bonus Shares vesting on second anniversary of Grant Date

Jelena Arsic van Os

Chief Executive Officer

526,435

421,148

105,287

Sameet Vohra

Chief Financial Officer

178,853

143,082

35,771

 

Long Term Incentive Plan 2025 Awards

Awards of nil cost options under the LTIP have been granted over a total of 1,883,769 Shares to various senior employees, including to the Executive Directors in such numbers as are set out below, in accordance with the terms of the LTIP Rules.

The nil cost options are expected to vest three years after grant, subject to the terms of the LTIP Rules, including continued employment of the beneficiaries by the Company and satisfaction of financial and non-financial performance conditions. Details of the performance conditions will be included in the FY26 Annual Report. A two-year holding period applies following the end of the performance period for Executive Directors only.

 

 

 

Director

Role

Number of nil cost options over Ordinary Shares awarded

Jelena Arsic van Os

Chief Executive Officer

778,693

Sameet Vohra

Chief Financial Officer

425,432

 

Following the awards made under the DBP, Jelena Arsic van Os is now beneficially interested in 509,398 Shares and Sameet Vohra is now beneficially interested in 143,082 Shares.

New Share Issues

 

In satisfaction of the grant of awards under the DBP as announced above, the Company further announces the issue of 2,248,645 Bonus Shares to the Company's Employee Benefit Trust ("EBT"), the beneficiaries of which include employees and the Executive Directors.

Application for admission of the Bonus Shares to trading on AIM and Euronext Amsterdam has now been made, with admission expected on or around 3 July 2025. The Company does not hold any shares in treasury. Therefore, the total voting rights in the Company following the issue of the Bonus Shares will be 242,694,212. Following the issue of the Bonus Shares, this figure may be used by shareholders as the denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company's securities under the FCA's Disclosure Guidance and Transparency Rules.

The Company shall make a further announcement once the sale of Shares, as is required to cover each Executive Director's respective tax and social security liabilities, has been completed in respect of the awards vesting on the Grant Date.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jelena Arsic van Os

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Award of Bonus Shares

Nil

526,435

2) LTIP 2025 award of nil cost options

Nil

778,693

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Sameet Vohra

2.

Reason for the notification

 

 

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

Award of Bonus Shares

Nil

178,853

LTIP 2025 award of nil cost options

Nil

425,432

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFBLFXEQLFBBF
Date   Source Headline
25th Jul 20184:58 pmRNSNotifiable Interest - Teslin Participaties
25th Jul 20184:51 pmRNSHolding(s) in Company
19th Jul 20187:00 amRNSNotifiable Interest - Teslin Participaties
18th Jul 20187:08 amRNSVP Participaties BV Issue of Shares
29th Jun 20184:25 pmRNSTotal Voting Rights
19th Jun 20185:00 pmRNSDirectors Interest EBT LTIP
19th Jun 20187:00 amRNSPreliminary Announcement
2nd May 20187:00 amRNSTrading Update Year Ending March 2018
1st May 20187:00 amRNSPurchase of Arnhem land and buildings
18th Apr 201810:21 amRNSNotifiable Interest - Teslin Participaties
3rd Apr 20187:00 amRNSNotifiable Interest - Teslin Participaties
16th Mar 20187:00 amRNSTricoya® licence agreement completed with FINSA
28th Feb 20182:20 pmRNSTotal Voting Rights
23rd Feb 20183:05 pmRNSIssue of Equity
6th Feb 20187:00 amRNSBoard Appointment
4th Jan 20184:01 pmRNSNotifiable Interest - Royal Bank of Canada
20th Dec 20172:23 pmRNSNotifiable Interest - Teslin
13th Dec 201710:52 amRNSNotifiable Interest - Decico
24th Nov 20179:34 amRNSNotifiable Interest - Decico
22nd Nov 20177:00 amRNSInterim Results for period ending 30 September 17
18th Oct 20171:18 pmRNSNotifiable Interest - Decico BV
12th Oct 20178:34 amRNSNotifiable Interest - Ineos
29th Sep 20174:00 pmRNSTotal Voting Rights
22nd Sep 20174:20 pmRNSDirectors Interest EBT LTIP
21st Sep 20175:09 pmRNSAGM Proxy Results
21st Sep 20177:00 amRNSAGM Statement
5th Sep 20172:36 pmRNSNotifiable Interest - Teslin
17th Aug 20175:11 pmRNSAGM Notification
18th Jul 20174:12 pmRNSNotifiable Interest - Teslin Participaties
12th Jul 20175:28 pmRNSEmployee Benefit Trust and Directors Interests
7th Jul 20177:00 amRNSNotifiable Interest - Todlin
6th Jul 20176:33 pmRNSNotifiable Interest - Teslin Participaties
30th Jun 201710:13 amRNSTotal Voting Rights
20th Jun 20174:28 pmRNS20170620 - Directors Interest EBT LTIP
20th Jun 20177:00 amRNSPreliminary Results
27th Apr 20175:19 pmRNSNotifiable Interest - Ineos Industries Holdings
27th Apr 20175:17 pmRNSNotifiable Interest - OP Group Central Cooperative
26th Apr 20171:32 pmRNSNotifiable Interest - OP Group Central Cooperation
26th Apr 20179:56 amRNSNotifiable Interest - FIL
25th Apr 20172:01 pmRNSNotifiable Interest - Todlin N.V.
24th Apr 20175:59 pmRNSDirector Dealings
24th Apr 20177:45 amRNSTotal Voting Rights
24th Apr 20177:00 amRNSTrading Update
21st Apr 201711:52 amRNSSuccessful Result of Firm Placing, Open offer & GM
29th Mar 20177:02 amRNSTricoya® Project, funding and equity raise
29th Mar 20177:00 amRNSTrading Update
28th Feb 201712:14 pmRNSTotal Voting Rights
3rd Feb 20173:56 pmRNSAccsys Employee Share Participation Plan
22nd Nov 20167:00 amRNSInterim results
30th Sep 20165:00 pmRNSHome Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.